>ff 3M 3M Specialty Materials 3M Center St.

BACK TO MAIN AR226-1030A036 Study Title Microbial Metabolism (Biodegradation) Studies of Perfluorooctane Sulfonate (PFOS) III.

ATTACHMENT TO LETTER OF JUNE 28, 2001 BACK TO COMPOUNDS 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE DOCUMENTS Click on Study Title to View Report COMPOUND-SPECIFIC STUDIES N-MeFOSE alcohol N-methyl perfluorooctane sulfonamidoethanol 1.

Decomposition of Perfluorooctane Sulfonate by Combustion Processes Introduction To understand the potential degradation pathways for perfluorinated chemicals, it was necessary to model the thermodynamics of incineration processes.

BACK TO MAIN ACUTE ORAL TOXICITY TO TERRESTRIAL INVERTEBRATES (HONEY BEE) TEST SUBSTANCE Identity: Perfluorooctanesulfonate; may also be referred to as PFOS or FC-95. (1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8heptadecafluoro-, potassium salt, CAS # 2795-39-3) Remarks field: The 3M production lot number was 217.

C O V /H H > THE DEVELOPMENT SERVICES COMPANY Sponsor: APME Ad-Hoc APFO Toxicology Working Group FINAL REPORT Study Title: 4-Week Capsule Toxicity Study with Ammonium Perfluorooctanoate (APFO) in Cynomolgus Monkeys Author: Peter J.

3M Medical Department Study: T-6889.3 Analytical Report: FACT TOX-026 LRN-U2782 Study Title 26-Week Capsule Toxicity Study with Ammonium Perfluorooctanoate (APFO/POAA) in Cynomolgus Monkeys Amended Analytical Laboratory Report Title Determination of the Presence and Concentration of Perfluorooctanoate Fluorochemical in Liver, Serum, Urine and Feces Samples Data Requirement Not Applicable Author 3M Environmental Laboratory Analytical Phase Completion Date June 11, 2001 Performing Laboratories Liver, Serum and Urine Analyses Feces Analyses 3M Environmental Laboratory Centre Analytical Laboratories, Inc.

3M General Offices 3M Center St.

NORTHERN KENTUCKY OFFICE SUITE *40 1*1' OlXiE HIGHWAY COVINGTON KENTUCKY4ian-A7C4 506-331-2036 513-361-2638 FAX 513-381-6613 Ro b e r t a .

3M Specialty Materials f January 3, 2003 3M Center St.

COVArfiCE^ THE DEVELOPMENT SERVICES COMPANY fiR AS. 6 -- 13 S'S' Sponsor: 3M St.

Aventis Pharma Aventis Pharma Deutschland GmbH Testing Facility Kastengrund ProTox Mainzer Landstr. 500 D - 65795 Hattersheim Germany AR226-1525 Aventis RECEIVED OPPT NCIC 03 SEP 30 PM1:00 TOXICOLOGY STUDY REPORT PT02-0222 T-7758 RAT REPEAT DOSE 28-DAY ORAL TOXICITY + 14-DAYS RECOVERY Author: Date: Original report for the sponsor Total pages: 464 Dr.

A Pharmacokinetic Study of Potassium Perfluorohexanesulfonate in the Cynomolgus Monkey Southern Research Institute Study ID: 9921.5 April 22, 2003 Final Report on A Pharmacokinetic Study of Potassium Perfluorohexanesulfonate in the Cynomolgus Monkey To: 3M Corporation P.O.

Larry R.

SRPT T-6295.8, T-6889.1, T-6316.4 DTI 5-A 3M MEDICAL DEPARTMENT, CORPORATE TOXICOLOGY Title; Inter-Species Comparison of Mechanisms Fluorochemicai Toxicity following Intraperitoneal dosing of perfluorooctanesulfonate (PFOS, T-6295) or ammonium perfluorooctanoate (APFO, T-6889) in Rats and Guinea Pigs and oral dosing of N-ethyl perfluorooctanesulfonamido ethanol (N-EtFOSE, T-6316) in Rats.